Elekta acquires Impac

After announcing its intent to merge in late January, Elekta AB this week finalized its acquisition of Mountain View, Calif.-based Impac Medical Systems Inc. Impac in now a wholly owned subsidiary of Elekta.
   
Under the terms of the agreement and plan of merger, Elekta will pay USD 24.00 in cash for each share of IMPAC common stock outstanding. Impac's common stock is no longer trading on the NASDAQ National Market, Elekta said.

Around the web

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

Trimed Popup
Trimed Popup